Trades on 3 secondary markets

Tizona Therapeutics

Tizona Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class cancer immunotherapies by translating novel scientific insights into new medicines. Its lead program, TTX-080, is a first-in-class HLA-G antagonist in clinical trials for advanced solid tumors. Tizona

minimal 5.7 / 100 0 APIs View provider profile →

Company Biotechnology Pharmaceuticals Immuno-Oncology Cancer Immunotherapy Healthcare

Tizona Therapeutics is an API provider whose private shares are listed on 3 secondary markets: Forge Global, Hiive, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.